Total results651
Search criteria
Number of publications supporting the inclusion of this protein in EV MemProt Atlas.
Annotation confidence score; open for threshold definitions.
Extremely high >= 0.70High >= 0.60Medium >= 0.40Low >= 0.30| UniProt ID | Protein names | Protein classification | Transmembrane count | Related Diseases | Mediation categories | Download | ||||
|---|---|---|---|---|---|---|---|---|---|---|
| CNNM4 | Q6P4Q7 | Metal transporter CNNM4 (Ancient conserved domain-containing protein 4) (Cyclin-M4) | Disease related genesHuman disease related genesPotential drug targets | 3 | Amelogenesis imperfectaCone-rod dystrophy | Fusion and delivery mediationMetabolism mediation | 6 | 0.63 | ||
| CSF1R | P07333 | Macrophage colony-stimulating factor 1 receptor (CSF-1 receptor) (CSF-1-R) (CSF-1R) (M-CSF-R) (EC 2.7.10.1) (Proto-oncogene c-Fms) (CD antigen CD115) | Cancer-related genesCD markersDisease related genes | 1 | Alzheimer diseaseBone/articular cartilage neoplasmDiabetes mellitus | Clinical-translation mediationImmune mediationReceptor-signaling mediation | 6 | 0.63 | ||
| ENPP3 | O14638 | Ectonucleotide pyrophosphatase/phosphodiesterase family member 3 (E-NPP 3) (NPP3) (Alkaline phosphodiesterase I) (EC 3.1.4.1) (Dinucleoside polyphosphatase) (EC 3.6.1.-) (Nucleotide diphosphatase) (Nucleotide pyrophosphatase) (NPPase) (EC 3.6.1.9) (Phosphodiesterase I beta) (PD-Ibeta) (Phosphodiesterase I/nucleotide pyrophosphatase 3) (CD antigen CD203c) | CD markersEnzymesMetabolic proteins | 1 | Renal cell carcinoma | Clinical-translation mediationFusion and delivery mediationImmune mediation | 6 | 0.63 | ||
| INSR | P06213 | Insulin receptor (IR) (EC 2.7.10.1) (CD antigen CD220) [Cleaved into: Insulin receptor subunit alpha; Insulin receptor subunit beta] | CD markersDisease related genesEnzymes | 1 | Diabetes mellitusAcute diabetic complicationAlzheimer disease | Adhesion and uptake mediationClinical-translation mediationFusion and delivery mediation | 6 | 0.63 | ||
| KCNN2 | Q9H2S1 | Small conductance calcium-activated potassium channel protein 2 (SK2) (SKCa 2) (SKCa2) (KCa2.2) | Disease related genesFDA approved drug targetsHuman disease related genes | 6 | DystoniaIntellectual disabilityMultiple myeloma | Clinical-translation mediationFusion and delivery mediation | 6 | 0.63 | ||
| LITAF | Q99732 | Lipopolysaccharide-induced tumor necrosis factor-alpha factor (LPS-induced TNF-alpha factor) (Small integral membrane protein of lysosome/late endosome) (p53-induced gene 7 protein) | Disease related genesHuman disease related genesPredicted intracellular proteins | Charcot-Marie-Tooth disease | Fusion and delivery mediationImmune mediationReceptor-signaling mediation | 6 | 0.63 | |||
| PRIO | P04156 | Major prion protein (PrP) (ASCR) (PrP27-30) (PrP33-35C) (CD antigen CD230) | CD markersDisease related genesHuman disease related genes | Amyloidosis | Adhesion and uptake mediationClinical-translation mediationFusion and delivery mediation | 19 | 0.60 | |||
| S10A9 | P06702 | Protein S100-A9 (Calgranulin-B) (Calprotectin L1H subunit) (Leukocyte L1 complex heavy chain) (Migration inhibitory factor-related protein 14) (MRP-14) (p14) (S100 calcium-binding protein A9) | Cancer-related genesPlasma proteinsPredicted intracellular proteins | Lupus erythematosusProstate cancer | Clinical-translation mediationFusion and delivery mediationImmune mediation | 18 | 0.60 | |||
| KPCD1 | Q15139 | Serine/threonine-protein kinase D1 (EC 2.7.11.13) (Protein kinase C mu type) (Protein kinase D) (nPKC-D1) (nPKC-mu) | Disease related genesEnzymesHuman disease related genes | Ectodermal dysplasiaSolid tumour/cancerUrinary system disease | Clinical-translation mediationFusion and delivery mediationImmune mediation | 16 | 0.60 | |||
| NOTC2 | Q04721 | Neurogenic locus notch homolog protein 2 (Notch 2) (hN2) [Cleaved into: Notch 2 extracellular truncation (N2ECD); Notch 2 intracellular domain (N2ICD)] | Cancer-related genesDisease related genesHuman disease related genes | 1 | OsteoporosisLung cancerPancreatic cancer | Clinical-translation mediationImmune mediationReceptor-signaling mediation | 16 | 0.60 |